STOCK TITAN

Penumbra, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 22, 2024

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Penumbra, Inc. (PEN) will host a conference call to discuss financial results for the fourth quarter and full year 2023 on February 22, 2024. The company will issue a press release with financial results after market close on the same day. The conference call can be accessed via phone or webcast, and the webcast will be available on the company's website for at least two weeks after the call.
Positive
  • None.
Negative
  • None.

ALAMEDA, Calif., Feb. 1, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2023 after market close on Thursday, February 22, 2024 at 4:30 PM Eastern Time. A press release with fourth quarter and full year 2023 financial results will be issued after market close that day.

Webcast & Conference Call Information
The conference call can be accessed live over the phone by dialing (888) 596-4144 for domestic and international callers (conference id: 4604622), or the webcast can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com. The webcast will be available on the company's website for at least two weeks following the completion of the call.

About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn.

Investor Relations

Penumbra, Inc.
510-995-2461
investors@penumbrainc.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-schedules-fourth-quarter-and-full-year-2023-earnings-release-and-conference-call-for-february-22-2024-302047427.html

SOURCE Penumbra, Inc.

Penumbra, Inc. will host a conference call on February 22, 2024.

The ticker symbol for Penumbra, Inc. is PEN.

The conference call can be accessed live over the phone or via webcast on the company's website.

The webcast will be available on the company's website for at least two weeks following the completion of the call.
Penumbra Inc

NYSE:PEN

PEN Rankings

PEN Latest News

PEN Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Health Technology, Medical Specialties, Manufacturing, Surgical and Medical Instrument Manufacturing
US
Alameda

About PEN

penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. we design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system. today we have over 1,000 employees with sales operations in north america, europe, australia and asia.